Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biling Weitong Granules vs Proton Pump Inhibitors for Functional Dyspepsia (Real-World Study)
ChiCTR2300072256Phase 4Not yet recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Sep 2022
- Countries
- 1
01
Overview
Phase 4, open-label trial of biling weitong granules in functional dyspepsia (FD) (3 arms), sponsored by Peking Union Medical College Hospital. Primary endpoint: Clinical efficacy rate. Planned start Sep 2022; status: not yet recruiting.
02
Drugs
biling weitong granules
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on ChiCTR2300072256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300072256.